Welcome to LookChem.com Sign In|Join Free
  • or
2H-1,4-Benzodiazepin-2-one, 3-azido-9-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

820215-05-2

Post Buying Request

820215-05-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

820215-05-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 820215-05-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,0,2,1 and 5 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 820215-05:
(8*8)+(7*2)+(6*0)+(5*2)+(4*1)+(3*5)+(2*0)+(1*5)=112
112 % 10 = 2
So 820215-05-2 is a valid CAS Registry Number.

820215-05-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-azido-9-chloro-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-1,4-benzodiazepine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:820215-05-2 SDS

820215-05-2Relevant academic research and scientific papers

BENZODIAZEPINE CGRP RECEPTOR ANTAGONISTS

-

Page 42-43, (2010/02/10)

The present invention is directed to compounds of Formula I: I (where variables R1, R2, R3, R6, R7, G, J, W, X and Y are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 820215-05-2